Immunotherapy drug doubles cancer survival in breakthrough trial
Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to an immunotherapy drug, a clinical trial suggests.This is the first sign of a breakthrough for patients with this difficult-to-treat cancer for 20 years, say scientists behind the research.Laura Marston, 45, from Derbyshire, says she is "amazed she's still here" after being given "dire" chances of survival following a diagnosis of advanced tongue cancer six years ago.She received the immunotherapy before and after surgery, which researchers say helps the body learn to attack the cancer if it returns.
Cancers in the head and neck are notoriously difficult to treat and there's been little change in the way patients are treated in two decades. More than half those diagnosed with advanced head and neck cancers die within five years.Laura was given only a 30% chance of surviving that long after her diagnosis in 2019, after having an ulcer on her tongue which wouldn't go away. The next step was major surgery to remove her tongue, as well as lymph nodes in her neck, and then she had to learn to talk and eat again."I was 39 and I was devastated," she told BBC News.As part of an international study into new ways to treat the cancer, involving experts from the Institute of Cancer Research in London, Laura was one of more than 350 patients given the immunotherapy drug pembrolizumab before and after surgery to prime the body's defences.Prof Kevin Harrington, who led the trial in the UK, explains: "We give the immune system the chance to have a good look at the tumour to generate anti-tumour immunity and then, after removal of the tumour, we continue to amplify that immune response by giving the drug continually for up to a year."A similar number of patients diagnosed with similar cancers received the usual care offered. They all had advanced head and neck cancers in one area, that had not spread to the rest of the body.The new approach showed positive results. It doubled the length of time patients were cancer free, on average, from around 2.5 years to five years.After three years, patients given pembrolizumab had a 10% lower risk of their cancer returning elsewhere in the body.
'Given me my life back'
Six years on, Laura is working full-time and says she's "in a good place and doing really well"."It's been phenomenal for me, because I'm here, able to talk to you."I wasn't expected to come this far," Laura says."My prognosis was quite dire." She had muscle taken from her left arm and placed into her mouth to fill the void left by her tongue. It has been a tough journey."Just having this amazing immunotherapy has given me my life back again."
The researchers say the key to their results was giving patients the drug before surgery, which trains the body to hunt down and kill the cancer if it ever comes back. Prof Harrington says immunotherapy "could change the world" for these patients."It significantly decreases the chance of cancer spreading around the body, at which point it's incredibly difficult to treat," he said.About 12,800 new head and neck cancer cases are diagnosed in the UK every year. The approach worked "particularly well" for some patients, but it was "really exciting" to see the treatment benefitting all the patients in the trial, Prof Harrington said. He added that it should now be made available on the NHS, .The study findings are being presented at the American Society of Clinical Oncology (ASCO) annual meeting.The trial, called Keynote, involved 192 hospitals in 24 countries, was led by Washington University Medical School in St Louis and funded by drug company MSD.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Auto Express
31 minutes ago
- Auto Express
Avoid using car finance claim firms, says financial watchdog
Consumers have been advised to steer clear of using car finance claim firms, as the UK's top financial watchdog says they could be spending money unnecessarily. The Financial Conduct Authority has begun setting out advice surrounding a possible redress scheme with regard to the ongoing car finance scandal which, according to experts, could see billions of pounds made available for potential claims. Advertisement - Article continues below However, with countless companies now popping up to assist potential claimants, the FCA is keen to remind motorists that in using one 'they may end up paying for a service they do not need and having to pay up to 30 per cent in fees out of any award they may receive'. Rather than utilise one of these paid services, consumers can submit timestamped complaints and claims themselves. Tools such as those on the MoneySavingExpert website can help people search for previous finance agreements, while the site also provides a template in order to draft a letter of complaint. With the Supreme Court set to make its judgement next month in regard to whether 'discretionary commission arrangements' (DCAs) were illegal in the first instance, the FCA is also advising finance firms on how they should calculate claims for disgruntled clients. The FCA is keen for a redress scheme to strike a balance between being fair to consumers, but at the same time not disrupting the market by putting finance firms out of business. In its latest release, the FCA says that the latter scenario could 'reduce competition and could make it more expensive for consumers to borrow money to buy a car in the future'. Such a scheme will fall under one of two arrangements: 'opt-in' and 'opt-out'. With the former – considered the most likely scenario – claimants would be required to notify their finance provider prior to a specified date if they wish to be considered for redress. 'Opt-out', on the other hand, would mean that everyone who is eligible will automatically be included, unless they contact their firm to be taken off the list. Consumers can expect the FCA to announce within six weeks of the Court's judgement in July as to whether a full redress scheme will be implemented, and how exactly it will operate. Tell us which new car you're interested in and get the very best offers from our network of over 5,500 UK dealers to compare. Let's go…
Telegraph
37 minutes ago
- Telegraph
The NHS truths the Left don't want you to hear
Until very recently, Health Secretary Wes Streeting tried to market himself as a radical health reformer, who is not afraid to poke sacred cows. While his reform-minded rhetoric always remained at a highly-abstract and general level, Streeting deserved some credit for it, because he did not have to do this. He had the courage to say things which he knew would rub some people up the wrong way, not least the Corbynite wing of his own party. Sadly, that brief period of NHS candour is now officially over. Streeting, the self-styled reformer, is no more. He and his colleagues have fully retreated into their comfort zone. During the recent local election campaign, Labour distributed a leaflet that showed a mock medical bill, and a doctor holding up a credit card reader. The message was clear: vote for us, because this is what the other lot want to do to you. On Twitter/X, Labour are now frequently posting dire warnings about the alleged evils of insurance-based healthcare systems. This is exactly that old-school NHS cultism which Streeting used to disavow until five minutes ago. It may work for him. The NHS may be falling apart, but the cult around is still going strong. In the eyes of its keenest defenders, the NHS can do no wrong. They have quietly dropped the old cliché about the NHS being 'the envy of the word', and replaced it with a slightly more subtle version, which goes something like this: Once upon a time, the NHS used to be the best healthcare system in the world. But then, from 2010 on, it was systematically defunded. It was deliberately run into the ground, so that it can be privatised more easily. A privatised system would mean luxury healthcare for the rich, and Wild West medicine for the poor. None of these claims are true. Let's have a look at each of them in turn. 'The NHS used to be the best healthcare system in the world' The NHS was never the best healthcare system in the world. The idea that it ever was can be traced back to a ranking compiled by the Commonwealth Fund, an American healthcare think tank, which relies on a very unusual methodology, in which medical outcomes only account for a fifth of the total score. This matters, because on medical outcomes, the NHS has always been one of the worst-performing healthcare systems in the developed world – as even the Commonwealth Fund study shows. There is no turning point after which the NHS's performance suddenly deteriorated. It was just never good in the first place. '…it was systematically defunded' At the end of the 2010s, age-adjusted real NHS spending per capita was only marginally higher than it had been in the beginning of the decade. Put differently, the NHS budget only just about kept pace with population growth, population ageing, and inflation. This clearly constituted a slowdown in spending increases compared to the previous decade. But it does not constitute a 'defunding'. In any case: that period of relative spending restraint is already over again. The NHS budget was given a massive boost during the pandemic, which has only been partially reversed. Public healthcare spending in the UK stands at just under 9% of GDP: one of the highest levels in the world. '…so that it can be privatised…' Conspiracy theories about secret plans to privatise the NHS have been around for decades. I wrote a report on this three years ago, for which I went through the news archives, and I found warnings about the NHS's imminent demise from every year since 1980. But somehow, it never happens. The NHS remains an unusually state-centred system. Most healthcare systems, including tax-funded ones, use a mix of public, private for-profit and private non-profit providers. 'A privatised system would mean luxury healthcare for the rich, and Wild West medicine for the poor' There are no plans – secret or otherwise – to privatise the NHS. More's the pity. Because there is nothing wrong with private healthcare systems. There are good examples of private, insurance-based healthcare systems, most notably in the Netherlands and Switzerland, which are nothing like the dreaded system of the US. These systems cover everybody: poor people are exempt from health insurance premiums and co-payments. Under these systems, rich and poor alike get faster access to medical treatment, and better medical outcomes, than they would on the NHS. The only thing these people don't get is a naff feel-good mythology around their health systems.
Telegraph
38 minutes ago
- Telegraph
Magic circle executive banned for sexual misconduct at karaoke bar
A former employee at one of London's most prestigious law firms has been banned from working in the legal profession after touching a junior colleague's bottom in a karaoke bar. Vivek Ramsaroop has been punished after the solicitors' watchdog found that he grabbed a fellow worker's waist and started 'rubbing himself' against her while on a work night. At the time, he was an employee at the magic circle firm Linklaters. The Solicitors Regulation Authority (SRA) has ruled that the incident, which took place in November 2022, amounted to 'serious sexual misconduct' and banned him from working for other law firms in Britain. As part of its findings, the SRA said Mr Ramsaroop harassed a junior colleague, referred to only as 'Employee A', at a social event organised for Linklaters' London office. The SRA said: 'Whilst at the karaoke bar, Mr Ramsaroop approached Employee A and stood closely to her talking and said the words 'you're gorgeous' and 'you're amazing'.' He then put his arms around her waist and kissed the side of her face for several seconds, the regulator said. 'Shortly afterwards, Mr Ramsaroop started dancing directly behind Employee A, grabbed her waist with both hands and touched her bottom,' the SRA added. Mr Ramaswoop then 'started rubbing himself against' his colleague on the dancefloor 'with his pelvis pressed against Employee A's bottom,' the watchdog said. During his time at Linklaters, Mr Ramaswoop – whose last known address was in Johannesburg – was involved in Linklaters' legal practice but not employed as a solicitor. He specialises in mergers and acquisitions. The SRA said Mr Ramaswoop's conduct constituted 'serious sexual misconduct' as it involved repeated physical contact directed towards a junior colleague. As a result, the regulator issued a so-called 'Section 43' notice against Mr Ramaswoop, which restricts firms from employing individuals deemed to have committed misconduct, even if they are not working as lawyers. Mr Ramaswoop was also ordered to pay a portion of the SRA's £1,350 legal bill. The regulator says it expects law firms to take a 'zero tolerance' approach to sexual misconduct, which covers any abuse of a person's 'professional position to initiate or pursue an improper sexual or emotional relationship'. Linklaters is one of Britain's four 'magic circle' law firms. Last year, it paid its partners an average £1.9m, while its newly-qualified lawyers received starting salaries of £150,000. A Linklaters spokesman said: 'This relates to an incident involving a former employee who had joined the firm a few weeks prior. We had reported the matter to the SRA and the individual left the firm with immediate effect.'
